CONA
MYGN icon

Capital One National Association’s Myriad Genetics MYGN Stock Holding History

Capital One National Association’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-36,478
Closed -$1.24M – 575
2014
Q4 		$1.24M Buy
36,478
+685
+2% +$24.3K 0.12% 208
2014
Q3 		$1.38M Buy
35,793
+11,421
+47% +$426K 0.14% 181
2014
Q2 		$949K Buy
24,372
+351
+1% +$13.1K 0.09% 245
2014
Q1 		$821K Buy
+24,021
New +$744K 0.08% 271
2013
Q3 		– Sell
-44,591
Closed -$1.2M – 546
2013
Q2 		$1.2M Buy
+44,591
New +$1.29M 0.13% 196

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital One National Association's MYGN Position: Q1 2015 in Review

Capital One National Association sold out of Myriad Genetics (MYGN) in Q1 2015, closing a stake of 36,478 shares — an estimated $1.24M sold.

Capital One National Association first reported a position in MYGN in Q2 2013 and held it in 5 quarters. The position peaked at $1.38M in Q3 2014. 251 funds tracked by Wall St. Rank hold MYGN as of Q1 2015.

  • Capital One National Association reported no remaining Myriad Genetics position as of Q1 2015 after selling out during the quarter.
  • Capital One National Association sold 36,478 Myriad Genetics shares in Q1 2015, an estimated $1.24M.
  • Capital One National Association first reported a position in Myriad Genetics in Q2 2013 and held it in 5 quarters.
  • Capital One National Association's Myriad Genetics position peaked at $1.38M in Q3 2014.
  • 251 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2015.

Based on Capital One National Association's 13F filing for Q1 2015, filed 21 Apr 2015.